The economic costs of non-insulin-dependent diabetes mellitus.
The economic costs of non-insulin-dependent diabetes mellitus.
复制标题
DOI：
10.1001/jama.1989.03430190092037
复制
发表时间：
1989-11
期刊：
影响因子：
--
通讯作者：
D. Huse;G. Oster;Alice R. Killen;M. Lacey;G. Colditz
中科院分区：
文献类型：
--
作者：
D. Huse;G. Oster;Alice R. Killen;M. Lacey;G. Colditz
与非糖尿病患者相比，糖尿病患者患各种其他疾病的风险增加，包括循环系统疾病、视觉疾病、神经系统疾病、肾脏疾病和皮肤疾病。然而，之前对糖尿病经济负担的估计没有充分考虑到相关的发病率和死亡率，因此低估了这种疾病给国家带来的成本。因此，我们估计了II型或非胰岛素依赖型糖尿病的经济成本，反映了其对美国疾病总负担的贡献。1986年，非胰岛素依赖型糖尿病造成了116亿美元的保健支出，其中68亿美元用于糖尿病护理，48亿美元用于相关疾病（主要是心血管疾病）的过度流行。非胰岛素依赖型糖尿病的人类死亡人数包括144，000人死亡-约占美国总死亡率的6.8%-以及951，000人的完全残疾。1986年，非胰岛素依赖型糖尿病的总经济负担，包括因残疾和过早死亡而损失的保健开支和生产力，为198亿美元。
Persons with diabetes experience elevated risks of a variety of other illnesses-- including circulatory, visual, neurological, renal, and skin disorders--relative to their nondiabetic peers. Previous estimates of the economic burden of diabetes, however, have not taken full account of this related morbidity and mortality and have therefore understated the cost to the nation due to this disease. Accordingly, we estimated the economic costs of type II, or non-insulin-dependent, diabetes mellitus, reflecting its contribution to the total burden of disease in the United States. In 1986, non-insulin-dependent diabetes mellitus was responsible for $11.6 billion in health care expenditures, including $6.8 billion for diabetic care and $4.8 billion attributable to an excess prevalence of related (principally cardiovascular) conditions. The human toll of non-insulin-dependent diabetes mellitus included 144,000 deaths -- about 6.8% of total US mortality -- and the total disability of 951,000 persons. The total economic burden of non-insulin-dependent diabetes mellitus in 1986, including health care expenditures and productivity forgone due to disability and premature mortality, was $19.8 billion.